NYSE:MMC

Marsh stock price (MRSH) dips as bond-sale filing lands and AI fears linger

Marsh & McLennan shares fell 0.71% to $174.09 by 2:39 p.m. EST Wednesday, following sector declines triggered by AI-driven insurance tools. The company filed for a new senior notes offering, with details pending, and registered up to 9 million shares for its stock award plan. Trading volume reached about 3 million shares. Marsh trades on the NYSE under ticker MRSH.

11 February 2026

Artificial Intelligence·NYSE:MMC·Stock Market

Marsh CEO Slams Rivals’ “Unlawful” Hiring Blitz as Shares Slide

Marsh & McLennan CEO John Doyle accused rivals of “unlawful and unethical” talent raids during the Oct. 16 earnings call, citing breaches of non-compete covenants. Marsh has sued competitors including Alliant and Howden over alleged poaching. Q3 revenue rose 11% to $6.4 billion, but shares dropped about 8%. Marsh will rebrand as “Marsh” in 2026 and launch a new Business & Client Services unit.

19 October 2025

NYSE:MMC·Stock Market

Marsh & McLennan’s Q3 Profit Jumps 11% Amid Rebrand to “Marsh” – What’s Next for MMC Stock?

Marsh & McLennan reported Q3 revenue of $6.4 billion, up 11% year-over-year, with adjusted EPS of $1.85, beating estimates. The firm will rebrand as “Marsh” in January 2026 and change its NYSE ticker to “MRSH.” Shares are down about 4% year-to-date, trading near $204. Wall Street rates the stock “Hold,” with an average price target of $237.

16 October 2025

NYSE:MMC·Stock Market

Organon Q1 CY2026 Revenue Falls Short of Estimates Amid Declining Sales
April 30, 2026, 10:38 PM EDT. Organon (NYSE:OGN) posted Q1 CY2026 revenue of $1.46 billion, missing analyst estimates by 0.7% and declining 3.5% year-on-year. The pharmaceutical firm reported adjusted earnings per share (EPS) of $0.71, 16.8% below expectations, and adjusted EBITDA slightly missed forecasts at $415 million. Despite a rising operating margin of 18.2%, revenue growth has been subdued, with annual declines of 1.5% over two years and stagnant sales near five-year levels. Market capitalization stands at $3.5 billion. Analysts anticipate flat revenue over the next 12 months, reflecting ongoing challenges in demand despite product innovation. The results raise concerns on Organon's business quality and long-term growth prospects in the women's health segment post its 2021 spinoff from Merck.

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026

Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026

Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026

Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.

NYSE:MMC 16 October 2025 - 11 February 2026